Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
10/2003
10/08/2003EP0920523B1 Hsv strain lacking functional icp27 and icp34.5 genes
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0566647B1 Improved humanized immunoglobulins
10/08/2003CN1447692A Methods of drug delivergy to hepatocytes and treatment of flaviviridae infections
10/07/2003US6630619 Insecticides; insecticidal proteins; genetic engineering; nematodes; symbionic bacteria; use of isolated polynucleotide encoding insecticidal protein to transform insect-specific viruses, bacteria, yeasts and plants to control insect pests
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630344 Adenoviral vectors; use for gene therapy, vaccines and for the transformation of cells
10/07/2003US6630343 Hepatitis C virus culture system
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/02/2003WO2003080846A1 Method of producing high-titre lentiviral vectors
10/02/2003WO2003080824A1 Hapatitis b viral packaging system
10/02/2003WO2003080823A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/02/2003WO2003080083A1 Use of adenoviruses mutated in the va genes for cancer treatment
10/02/2003WO2003049765A3 Enveloped virus vaccine and method for production
10/02/2003WO2002081712A3 Artificial chromosomes comprising ehv sequences
10/02/2003WO2002079239A3 Chimeric filovirus glycoprotein
10/02/2003US20030186431 Rabbit hemorrhagic disease vaccine and antigens
10/02/2003US20030186424 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
10/02/2003US20030186415 Mutant possessing uracil phosphoribosyl transferase activity
10/02/2003US20030186406 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186307 Propagating and replicating procine circoviruses (PCV) for use in vaccine development and as diagnostic aides detecting viral infection in swine; animal husbandry
10/02/2003US20030186254 Comprises nucleotide sequences coding serine/threonine kinase (PAK4) which effects guanyl-nucleotide exchange factor (GEF) activity for diagnosis and treatment of viral diseases
10/02/2003US20030186236 Diagnosis and prevention of infectibity of swine with porcine reproductive and respiratory syndrome virus; viricides; animal husbandry
10/02/2003US20030186225 Comprises DNA sequences coding viral protein for use in developing vaccine which prevents porcine reproductive and respiratory syndrome viral infections
10/02/2003US20030186219 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
10/02/2003US20030185855 Which has lost its transducing properties as a result of a DNA sequence change in the gene coding for Vmw65 protein; expressable heterologous gene inserted; under the control of the immediate early 1 gene enhancer of cytomegalovirus
10/02/2003US20030185801 Packaging cell line capable of complementing recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35.
10/02/2003CA2479897A1 Bacteriophages useful for therapy and prophylaxis of bacterial infections
10/01/2003EP1348445A1 Method for separating viruses from a protein solution by nanofiltration
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348026A2 Fibrin binding moieties useful as imaging agents
10/01/2003CN1446102A Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens
10/01/2003CN1122531C Method for industrially producing Japanese encephalitis vaccine, and resulting vaccine
09/2003
09/30/2003US6627610 Treat a viral infection in a subject via inhibiting the prenylation of a protein contained in the virus infecting said subject, which method comprises administering to said subject an agent selected from the group consisting of amino
09/30/2003US6627442 Methods for stable transduction of cells with hiv-derived viral vectors
09/30/2003US6627395 Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1)
09/30/2003US6627202 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
09/27/2003CA2422343A1 Compositions and methods for increasing plant growth by inoculation with bacillus strains
09/25/2003WO2003078641A1 Engineered baculoviruses and their use
09/25/2003WO2003078628A1 Methods for peptide and protein display in nucleic acid arrays
09/25/2003WO2003078592A2 Method for the purification, production and formulation of oncolytic adenoviruses
09/25/2003WO2003078455A2 Virus like particle from papillomavirus and their use in vaccine
09/25/2003WO2003077942A2 Virus-like particles of human papillomavirus
09/25/2003WO2003077853A2 Immortal porcine cells
09/25/2003WO2003060101A3 Gene delivery system and methods of use
09/25/2003WO2003016521A3 Aav vector packaging plasmid for producing wtaav particles or pseudotyped aav particles without helper viruses, by means of a single transfection
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003001210A3 Retrovirus associated with myelodysplastic syndromes
09/25/2003WO2002092826A3 Composition and method for treating cancer using herpes virus
09/25/2003US20030182688 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants
09/25/2003US20030182674 Method of making a genetically modified mammal
09/25/2003US20030181659 Thrombopoietin receptor modulating peptide
09/25/2003US20030181355 Inhibiting viral morphogenesis and viral infection. In particular, it concerns effecting such inhibition by inhibiting the prenylation or post prenylation reactions of a viral or host protein.
09/25/2003US20030180936 Method for the purification, production and formulation of oncolytic adenoviruses
09/25/2003US20030180759 Antigen derived from the gp160 env precursor protein (glycoprotein120 envelop protein)of a HIV-1 group O strain contains an amino acid sequence characterized by the fact that it reacts with antibodies raised against such antigen
09/25/2003US20030180372 Water in oil emulsion; inoculating lymph nodes of pregnancy goat with virus
09/25/2003US20030180329 Induction nucleic acids into cell; forming vaccine
09/25/2003US20030180324 Lentivirus from the group of immunodeficiency viruses of drill monkeys (Mandrillus leucophaeus) and their use
09/25/2003US20030180322 Genome segments; detection of phenotype
09/25/2003US20030180319 Mutant bacteriophages; genetic engineering
09/25/2003US20030180261 Vaccines; cancer therapy; immobilization of virus; supplying tumor
09/25/2003CA2479307A1 Virus like particle from papillomavirus and their use in vaccine
09/25/2003CA2479304A1 Virus-like particles of human papillomavirus
09/25/2003CA2478692A1 Engineered baculoviruses and their use
09/24/2003EP1347042A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it
09/24/2003EP1346058A2 Adenoviral systems and the uses thereof
09/24/2003EP1346036A2 Helper virus-free herpes virus amplicon particles and uses thereof
09/24/2003EP1345622A2 Eiav chimeric vaccine and diagnostic
09/24/2003CN1443844A Hepatitis A virus strain, method for preparing hepatitis A inactivated vaccine and obtained vaccine
09/24/2003CN1122105C Novel method viruses, anti viral compounds and novel methods of making vaccines
09/23/2003US6623952 Infectious; of given sequence; may be used as a vector for gene therapy, in a vaccine or for detection of viruses for xenotransplantation
09/23/2003CA1341439C Feline t-lymphotropic lentivirus
09/18/2003WO2003076607A1 Recovery of viruses
09/18/2003WO2003076606A1 High throughput system for producing recombinant viruses using site-specific recombination
09/18/2003WO2003076605A1 A method for producing recombinant viruses using site-specific recombination
09/18/2003WO2003076596A2 Altering viral tropism
09/18/2003WO2003076591A2 Compositions and methods for generating an immune response
09/18/2003WO2003076583A2 Genetically engineered phage and the use of genetically engineered phage to deliver nucleic acid to bacteria
09/18/2003WO2003076462A1 Use of recombinant trypsin for vaccine production
09/18/2003WO2003025191A3 Pseudotyped retroviral vector system
09/18/2003WO2003022878A3 Subunit respiratory syncytial virus vaccine preparation
09/18/2003WO2003008599A3 System for producing clonal or complex populations of recombinant adenoviruses, and the application of the same
09/18/2003WO2002000687A9 Antimicrobial peptides and methods of use thereof
09/18/2003US20030177523 Isolated nucleic acid; genetic engineering
09/18/2003US20030177509 Mouse model for HIV infection utilizing a chimeric HIV/MLV Gag protein that permits efficient assembly from murine cells
09/18/2003US20030175952 Binding lecithin to virus; concentration; efficient gene expression; culturing; purification
09/18/2003US20030175919 ITI-D1 Kunitz domain mutants as hNE inhibitors
09/18/2003US20030175907 Method of constructing a synthetic polynucleotide
09/18/2003US20030175881 Nucleic acids encoding (poly) peptides having chips activity
09/18/2003US20030175693 HIV recombinant vaccine
09/18/2003US20030175692 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease
09/18/2003US20030175688 Preparing replication competent viral vectors for treating cancer; genetic vaccines; gene therapy; antitumor agents
09/18/2003US20030175683 In vitro system for replication of RNA-dependent RNA polymerase (RDRP) viruses
09/18/2003US20030175304 Recombinant dimeric envelope vaccine against flaviviral infection
09/18/2003US20030175302 Avian pneumovirus vaccine
09/18/2003US20030175301 Rotavirus pseudoviral particles and use thereof for vectorizing proteins of nucleic acids
09/18/2003US20030175296 Chimaeric hepadnavirus core antigen proteins
09/18/2003US20030175292 Compositions and methods for generating an immune response
09/18/2003US20030175246 Toxin-phage bacteriocide antibiotic and uses thereof
1 ... 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 ... 267